A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

• Status: Completed
• Trial end date: 2013-07-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Glabellar lines and crow's feet lines

• No prior use of botulinum toxin therapy of any serotype for any reason

Exclusion Criteria:

• Previous facial cosmetic surgery, tissue grafting, or tissue augmentation with silicone or fat or other permanent fillers

• Planning a facial cosmetic procedure during the study period

• Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, and/or amyotrophic lateral sclerosis

• Anticipated need for treatment with botulinum toxin of any serotype for any reason during the study (other than study treatment)